Results 231 to 240 of about 813,932 (302)

Multiple Retransplantations After BK Polyomavirus-Associated Metastatic Collecting Duct Carcinoma: Evidence for Protective BK-specific T-Cell Immunity. [PDF]

Transplantation
Hammer N, Khanna N, Haidar F, Hirsch HH.
europepmc   +1 more source

Long‐term cost‐effectiveness of belatacept vs. tacrolimus in kidney transplantation: Trade‐off between metabolic benefit and immunological risk

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the long‐term cost‐effectiveness of belatacept vs. tacrolimus as maintenance immunosuppression in adult kidney transplant recipients, focusing on the trade‐off between reduced new‐onset diabetes after transplantation (NODAT), immunological risk and potential renal benefit.
Salvatore Di Maria, Carmelo Puglia, Alessio Provenzani   +2 more
wiley   +1 more source

Pulmonary Rehabilitation in Inborn Errors of Immunity with Bronchiectasis: A Narrative Review with Implications for High-Consanguinity Settings. [PDF]

J Clin Med
Alruwaili R, Albelasi A, Alqahtani MM.
europepmc   +1 more source

Extracellular Vesicles‐Based Biological Macromolecule Delivery Systems: Biogenesis, Characterization, and Emerging Clinical Applications

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale membrane‐bound structures that play a pivotal role in intercellular communication by transporting bioactive molecules, including proteins, lipids, nucleic acids, and organelles, between cells. Originating from the endosomal pathway, EVs reflect the physiological and pathological status of their parent
Emine İncilay Torunoğlu, Zeynep Betül Sarı, Muhammed Emin Sarı, Erdi Can Aytar   +3 more
wiley   +1 more source

Editorial: Innovative approaches to immunogenetics and organ transplantation. [PDF]

Front Immunol
Süsal C, Morath C.
europepmc   +1 more source

Immunology/Transplantation

Diabetes, 2012
openaire   +2 more sources

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Correction to "Sustained Effector Functions and Memory Accumulation of αβ T Cells in Children With Congenital Heart Disease". [PDF]

Eur J Immunol
europepmc   +1 more source

Correction: <i>De novo</i> and quiescent cGVHD are distinguishable in a prognostic biomarker panel. [PDF]

Front Immunol
Vollmer L, Habenicht KM, Schneider A, Fante M, Mackensen A, Winkler J, Wolff D, Winkler TH.   +7 more
europepmc   +1 more source

Establishing "Glycoantigens" as a cross-field concept in Glycobiology, transfusion, transplant, and immunology. [PDF]

Hum Immunol
Lane WJ.
europepmc   +1 more source